Bacterial Infection Due to Streptococcus, Group B
1 clinical trials · Condition
◉ Watch Bacterial Infection Due to Streptococcus, Group B
| Record | Firm | Date |
|---|---|---|
| Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects. (NCT02690181) | GlaxoSmithKline | 2016-03-29 |
Track Bacterial Infection Due to Streptococcus, Group B automatically
Every clearance here is in the API, with alerts when new ones post.